Be Mindful of Hunger Signals One of the biggest changes after GLP-1 therapy is the return of natural hunger cues
GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)commonly affect bowel movements, though responses vary widely among patients
Semaglutide was developed in 2012 by a Danish pharmaceutical company called Novo Nordisk in an attempt to design an analogue of GLP-1 with long life that is resistant to degradation
It provides a longer lasting feeling of fullness after eating and thats just one way it makes it so much easier for patients to lose weight
thus, maybe provide therapeutic effect in bladder injuries ( Anagallis arvensis Anagallis arvensis, a medicinal herb of the Primulaceae family contains enormous phytochemicals such as kaempferol, quercetin, saponins, anagallosides A and B, cucurbitacin B and D, sterols, etc